255 related articles for article (PubMed ID: 31035190)
1. Clonazepam for probable REM sleep behavior disorder in Parkinson's disease: A randomized placebo-controlled trial.
Shin C; Park H; Lee WW; Kim HJ; Kim HJ; Jeon B
J Neurol Sci; 2019 Jun; 401():81-86. PubMed ID: 31035190
[TBL] [Abstract][Full Text] [Related]
2. Melatonin for rapid eye movement sleep behavior disorder in Parkinson's disease: A randomised controlled trial.
Gilat M; Coeytaux Jackson A; Marshall NS; Hammond D; Mullins AE; Hall JM; Fang BAM; Yee BJ; Wong KKH; Grunstein RR; Lewis SJG
Mov Disord; 2020 Feb; 35(2):344-349. PubMed ID: 31674060
[TBL] [Abstract][Full Text] [Related]
3. Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group.
Schenck CH; Montplaisir JY; Frauscher B; Hogl B; Gagnon JF; Postuma R; Sonka K; Jennum P; Partinen M; Arnulf I; Cochen de Cock V; Dauvilliers Y; Luppi PH; Heidbreder A; Mayer G; Sixel-Döring F; Trenkwalder C; Unger M; Young P; Wing YK; Ferini-Strambi L; Ferri R; Plazzi G; Zucconi M; Inoue Y; Iranzo A; Santamaria J; Bassetti C; Möller JC; Boeve BF; Lai YY; Pavlova M; Saper C; Schmidt P; Siegel JM; Singer C; St Louis E; Videnovic A; Oertel W
Sleep Med; 2013 Aug; 14(8):795-806. PubMed ID: 23886593
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy of prolonged-release melatonin versus clonazepam for isolated rapid eye movement sleep behavior disorder.
Byun JI; Shin YY; Seong YA; Yoon SM; Hwang KJ; Jung YJ; Cha KS; Jung KY; Shin WC
Sleep Breath; 2023 Mar; 27(1):309-318. PubMed ID: 35141811
[TBL] [Abstract][Full Text] [Related]
5. Rapid eye movement sleep behavior disorder.
Gugger JJ; Wagner ML
Ann Pharmacother; 2007 Nov; 41(11):1833-41. PubMed ID: 17925503
[TBL] [Abstract][Full Text] [Related]
6. Effects of long-term use of clonazepam on nonrapid eye movement sleep patterns in rapid eye movement sleep behavior disorder.
Ferri R; Zucconi M; Marelli S; Plazzi G; Schenck CH; Ferini-Strambi L
Sleep Med; 2013 May; 14(5):399-406. PubMed ID: 23490738
[TBL] [Abstract][Full Text] [Related]
7. Use of ramelteon for the treatment of secondary REM sleep behavior disorder.
Nomura T; Kawase S; Watanabe Y; Nakashima K
Intern Med; 2013; 52(18):2123-6. PubMed ID: 24042525
[TBL] [Abstract][Full Text] [Related]
8. REM sleep behavior disorder in patients with Parkinson's disease.
Poryazova RG; Zachariev ZI
Folia Med (Plovdiv); 2005; 47(1):5-10. PubMed ID: 16152765
[TBL] [Abstract][Full Text] [Related]
9. A prospective, naturalistic follow-up study of treatment outcomes with clonazepam in rapid eye movement sleep behavior disorder.
Li SX; Lam SP; Zhang J; Yu MW; Chan JW; Liu Y; Lam VK; Ho CK; Zhou J; Wing YK
Sleep Med; 2016 May; 21():114-20. PubMed ID: 27448481
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD.
Iranzo A; Santamaría J; Rye DB; Valldeoriola F; Martí MJ; Muñoz E; Vilaseca I; Tolosa E
Neurology; 2005 Jul; 65(2):247-52. PubMed ID: 16043794
[TBL] [Abstract][Full Text] [Related]
11. Retinal nerve fiber layer thinning: a window into rapid eye movement sleep behavior disorders in Parkinson's disease.
Yang ZJ; Wei J; Mao CJ; Zhang JR; Chen J; Ji XY; Liu JY; Shen Y; Xiong KP; Huang JY; Yang YP; Liu CF
Sleep Breath; 2016 Dec; 20(4):1285-1292. PubMed ID: 27259748
[TBL] [Abstract][Full Text] [Related]
12. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases.
Olson EJ; Boeve BF; Silber MH
Brain; 2000 Feb; 123 ( Pt 2)():331-9. PubMed ID: 10648440
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of REM sleep behavior disorder in Parkinson's disease.
Nomura T; Inoue Y; Kagimura T; Nakashima K
Sleep Med; 2013 Feb; 14(2):131-5. PubMed ID: 23218532
[TBL] [Abstract][Full Text] [Related]
14. [REM sleep behavior disorder (RBD)].
Ylikoski A; Partinen M
Duodecim; 2012; 128(15):1602-6. PubMed ID: 22970612
[TBL] [Abstract][Full Text] [Related]
15. A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder.
Kunz D; Mahlberg R
J Sleep Res; 2010 Dec; 19(4):591-6. PubMed ID: 20561180
[TBL] [Abstract][Full Text] [Related]
16. Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients.
Boeve BF; Silber MH; Ferman TJ
Sleep Med; 2003 Jul; 4(4):281-4. PubMed ID: 14592300
[TBL] [Abstract][Full Text] [Related]
17. Update on the pharmacology of REM sleep behavior disorder.
Gagnon JF; Postuma RB; Montplaisir J
Neurology; 2006 Sep; 67(5):742-7. PubMed ID: 16966533
[TBL] [Abstract][Full Text] [Related]
18. Visual hallucinations as REM sleep behavior disorders in patients with Parkinson's disease.
Nomura T; Inoue Y; Mitani H; Kawahara R; Miyake M; Nakashima K
Mov Disord; 2003 Jul; 18(7):812-7. PubMed ID: 12815661
[TBL] [Abstract][Full Text] [Related]
19. Cannabidiol for Rapid Eye Movement Sleep Behavior Disorder.
de Almeida CMO; Brito MMC; Bosaipo NB; Pimentel AV; Tumas V; Zuardi AW; Crippa JAS; Hallak JEC; Eckeli AL
Mov Disord; 2021 Jul; 36(7):1711-1715. PubMed ID: 33754375
[TBL] [Abstract][Full Text] [Related]
20. Associations between probable REM sleep behavior disorder, olfactory disturbance, and clinical symptoms in Parkinson's disease: A multicenter cross-sectional study.
Iijima M; Okuma Y; Suzuki K; Yoshii F; Nogawa S; Osada T; Hirata K; Kitagawa K; Hattori N
PLoS One; 2021; 16(2):e0247443. PubMed ID: 33606814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
